Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey

No Thumbnail Available

Authors

Monk, B. J.
Lammers, P. E.
Cartwright, T.
Jacobs, I.

Issue Date

2017

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Monk, B. J.; Lammers, P. E.; Cartwright, T.; Jacobs, I. (2017). Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey. Pharmaceuticals (Basel), January 2017, 10(1):(11 pages). doi: http://dx.doi.org/10.3390/ph10010019

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

ISSN

1424-8247

EISSN